Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 238 | 2024 | 6230 | 21.560 |
Why?
|
Allergens | 88 | 2024 | 1433 | 11.850 |
Why?
|
Air Pollution, Indoor | 51 | 2024 | 900 | 10.570 |
Why?
|
Schools | 51 | 2024 | 1483 | 8.440 |
Why?
|
Environmental Exposure | 80 | 2024 | 4479 | 7.860 |
Why?
|
Hypersensitivity | 36 | 2024 | 1167 | 7.180 |
Why?
|
Anti-Asthmatic Agents | 32 | 2024 | 573 | 5.840 |
Why?
|
Food Hypersensitivity | 24 | 2024 | 726 | 5.380 |
Why?
|
Urban Population | 36 | 2024 | 2036 | 5.320 |
Why?
|
Bronchodilator Agents | 17 | 2022 | 512 | 3.350 |
Why?
|
Cockroaches | 16 | 2022 | 97 | 3.060 |
Why?
|
Adrenal Cortex Hormones | 35 | 2024 | 1878 | 2.920 |
Why?
|
Dust | 16 | 2024 | 486 | 2.640 |
Why?
|
Child | 201 | 2024 | 80152 | 2.590 |
Why?
|
Skin Tests | 19 | 2020 | 638 | 2.570 |
Why?
|
Eczema | 7 | 2024 | 246 | 2.470 |
Why?
|
Immunoglobulin E | 27 | 2023 | 1505 | 2.470 |
Why?
|
Egg Hypersensitivity | 5 | 2020 | 47 | 2.320 |
Why?
|
Dermatitis, Atopic | 11 | 2024 | 731 | 2.220 |
Why?
|
Fungi | 13 | 2023 | 337 | 2.140 |
Why?
|
Housing | 14 | 2023 | 669 | 1.910 |
Why?
|
Pest Control | 4 | 2019 | 29 | 1.740 |
Why?
|
School Health Services | 8 | 2024 | 384 | 1.570 |
Why?
|
Endotoxins | 5 | 2018 | 520 | 1.570 |
Why?
|
Spirometry | 12 | 2024 | 928 | 1.510 |
Why?
|
Desensitization, Immunologic | 9 | 2024 | 557 | 1.500 |
Why?
|
Biological Products | 7 | 2023 | 915 | 1.470 |
Why?
|
Hypersensitivity, Immediate | 9 | 2024 | 348 | 1.420 |
Why?
|
Child, Preschool | 79 | 2024 | 42224 | 1.390 |
Why?
|
Milk Hypersensitivity | 3 | 2020 | 82 | 1.350 |
Why?
|
Air Pollutants | 17 | 2024 | 2889 | 1.330 |
Why?
|
Nitrogen Dioxide | 5 | 2024 | 521 | 1.290 |
Why?
|
Humans | 325 | 2024 | 761208 | 1.280 |
Why?
|
Ibuprofen | 3 | 2021 | 229 | 1.270 |
Why?
|
Pyroglyphidae | 7 | 2018 | 89 | 1.230 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 4 | 2019 | 110 | 1.220 |
Why?
|
Air Pollution | 9 | 2024 | 2351 | 1.180 |
Why?
|
Respiratory Sounds | 8 | 2021 | 702 | 1.150 |
Why?
|
Administration, Inhalation | 25 | 2024 | 1159 | 1.130 |
Why?
|
Urban Health | 6 | 2019 | 532 | 1.100 |
Why?
|
Cats | 12 | 2018 | 974 | 1.100 |
Why?
|
Viruses | 2 | 2021 | 372 | 1.090 |
Why?
|
Forced Expiratory Volume | 20 | 2024 | 1813 | 1.070 |
Why?
|
Psychology | 2 | 2019 | 356 | 1.050 |
Why?
|
Respiratory Function Tests | 16 | 2024 | 1685 | 1.000 |
Why?
|
Morbidity | 15 | 2023 | 1751 | 0.960 |
Why?
|
Adolescent | 91 | 2024 | 88298 | 0.950 |
Why?
|
Ovomucin | 2 | 2013 | 7 | 0.900 |
Why?
|
Snoring | 2 | 2024 | 209 | 0.860 |
Why?
|
Antigens, Dermatophagoides | 7 | 2021 | 98 | 0.840 |
Why?
|
Caregivers | 9 | 2024 | 2244 | 0.840 |
Why?
|
Air Microbiology | 3 | 2019 | 95 | 0.840 |
Why?
|
Anaphylaxis | 5 | 2019 | 758 | 0.790 |
Why?
|
Phthalic Acids | 2 | 2024 | 478 | 0.790 |
Why?
|
Rodent Control | 1 | 2021 | 15 | 0.780 |
Why?
|
Mice | 38 | 2024 | 81326 | 0.780 |
Why?
|
Dogs | 11 | 2022 | 3832 | 0.780 |
Why?
|
Rodenticides | 2 | 2021 | 21 | 0.770 |
Why?
|
Male | 139 | 2024 | 360693 | 0.770 |
Why?
|
Eggs | 2 | 2013 | 182 | 0.760 |
Why?
|
Medication Adherence | 9 | 2024 | 2175 | 0.750 |
Why?
|
Spores, Fungal | 2 | 2019 | 90 | 0.750 |
Why?
|
Female | 142 | 2024 | 392544 | 0.730 |
Why?
|
Eosinophils | 10 | 2024 | 951 | 0.720 |
Why?
|
Nut Hypersensitivity | 2 | 2010 | 33 | 0.720 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 124 | 0.710 |
Why?
|
Pregnenediones | 4 | 2022 | 29 | 0.710 |
Why?
|
Rodentia | 3 | 2019 | 261 | 0.710 |
Why?
|
Cities | 6 | 2024 | 541 | 0.700 |
Why?
|
Ozone | 1 | 2023 | 482 | 0.680 |
Why?
|
Virus Diseases | 2 | 2017 | 716 | 0.680 |
Why?
|
Animals | 75 | 2024 | 168079 | 0.680 |
Why?
|
Acetaminophen | 4 | 2021 | 555 | 0.670 |
Why?
|
Nitric Oxide | 7 | 2023 | 2136 | 0.660 |
Why?
|
Rhinovirus | 5 | 2023 | 203 | 0.650 |
Why?
|
Alternaria | 1 | 2019 | 42 | 0.640 |
Why?
|
Anti-Allergic Agents | 2 | 2020 | 153 | 0.640 |
Why?
|
Climate Change | 3 | 2017 | 498 | 0.640 |
Why?
|
Vehicle Emissions | 2 | 2024 | 655 | 0.630 |
Why?
|
Epinephrine | 3 | 2017 | 791 | 0.630 |
Why?
|
Mentors | 1 | 2024 | 663 | 0.620 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 249 | 0.620 |
Why?
|
Acute Chest Syndrome | 1 | 2018 | 32 | 0.620 |
Why?
|
Hospitals, Pediatric | 2 | 2018 | 1862 | 0.610 |
Why?
|
Insect Bites and Stings | 2 | 2017 | 71 | 0.590 |
Why?
|
Albuterol | 5 | 2019 | 211 | 0.590 |
Why?
|
Respiratory Tract Diseases | 2 | 2013 | 748 | 0.580 |
Why?
|
Exhalation | 2 | 2016 | 182 | 0.570 |
Why?
|
Oxidants, Photochemical | 1 | 2017 | 76 | 0.570 |
Why?
|
Inhalation Exposure | 1 | 2020 | 432 | 0.570 |
Why?
|
Students | 9 | 2023 | 1737 | 0.570 |
Why?
|
Policy | 2 | 2019 | 506 | 0.550 |
Why?
|
Maximal Midexpiratory Flow Rate | 2 | 2016 | 75 | 0.550 |
Why?
|
Double-Blind Method | 22 | 2024 | 12341 | 0.540 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2015 | 355 | 0.540 |
Why?
|
Jews | 1 | 2018 | 356 | 0.530 |
Why?
|
Obesity | 10 | 2023 | 12939 | 0.520 |
Why?
|
Plant Proteins | 2 | 2021 | 374 | 0.520 |
Why?
|
Severity of Illness Index | 25 | 2024 | 15841 | 0.510 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 4 | 2022 | 57 | 0.510 |
Why?
|
Bronchoconstriction | 1 | 2016 | 141 | 0.500 |
Why?
|
Toxocariasis | 1 | 2015 | 12 | 0.500 |
Why?
|
Infant | 30 | 2024 | 36169 | 0.490 |
Why?
|
Picornaviridae Infections | 3 | 2023 | 95 | 0.490 |
Why?
|
Enterocolitis | 3 | 2021 | 106 | 0.480 |
Why?
|
Particulate Matter | 10 | 2024 | 2597 | 0.470 |
Why?
|
Terbutaline | 1 | 2014 | 23 | 0.470 |
Why?
|
Mycoses | 1 | 2017 | 386 | 0.460 |
Why?
|
United States | 33 | 2024 | 72339 | 0.460 |
Why?
|
Prevalence | 12 | 2024 | 15721 | 0.460 |
Why?
|
Trees | 1 | 2014 | 57 | 0.450 |
Why?
|
Asthma, Exercise-Induced | 1 | 2013 | 23 | 0.450 |
Why?
|
Egg White | 1 | 2013 | 16 | 0.450 |
Why?
|
Milk | 3 | 2020 | 440 | 0.440 |
Why?
|
Peanut Hypersensitivity | 2 | 2021 | 219 | 0.440 |
Why?
|
Immune System | 1 | 2019 | 792 | 0.440 |
Why?
|
Sesamum | 2 | 2010 | 20 | 0.440 |
Why?
|
Sputum | 5 | 2024 | 505 | 0.430 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2014 | 105 | 0.430 |
Why?
|
Nasal Mucosa | 2 | 2019 | 413 | 0.430 |
Why?
|
Environmental Monitoring | 6 | 2024 | 1460 | 0.420 |
Why?
|
Immune Tolerance | 3 | 2020 | 2307 | 0.420 |
Why?
|
Pneumonia | 2 | 2022 | 2142 | 0.420 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 217 | 0.410 |
Why?
|
Parents | 5 | 2014 | 3564 | 0.410 |
Why?
|
Immunization | 4 | 2010 | 1218 | 0.410 |
Why?
|
Ipratropium | 2 | 2016 | 19 | 0.410 |
Why?
|
Social Class | 4 | 2024 | 1993 | 0.410 |
Why?
|
Acetates | 3 | 2019 | 319 | 0.410 |
Why?
|
Antibodies, Monoclonal | 5 | 2023 | 9187 | 0.400 |
Why?
|
Quality of Life | 14 | 2024 | 13367 | 0.400 |
Why?
|
Genes, Regulator | 1 | 2013 | 373 | 0.400 |
Why?
|
Pesticides | 1 | 2015 | 296 | 0.400 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2317 | 0.390 |
Why?
|
Education | 1 | 2015 | 536 | 0.390 |
Why?
|
Immunity | 1 | 2017 | 996 | 0.380 |
Why?
|
Radon | 2 | 2023 | 87 | 0.380 |
Why?
|
Computer-Assisted Instruction | 1 | 2015 | 362 | 0.380 |
Why?
|
Health Surveys | 2 | 2019 | 4037 | 0.380 |
Why?
|
Pets | 3 | 2019 | 46 | 0.380 |
Why?
|
Prospective Studies | 26 | 2024 | 54435 | 0.370 |
Why?
|
Prolactin | 1 | 2013 | 625 | 0.370 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7804 | 0.360 |
Why?
|
Cross Reactions | 2 | 2023 | 819 | 0.360 |
Why?
|
Edema | 1 | 2015 | 764 | 0.360 |
Why?
|
Specimen Handling | 1 | 2015 | 702 | 0.350 |
Why?
|
Minority Groups | 8 | 2022 | 1201 | 0.350 |
Why?
|
Bronchiolitis | 1 | 2017 | 485 | 0.350 |
Why?
|
Antibody Specificity | 1 | 2012 | 1059 | 0.350 |
Why?
|
Vital Capacity | 5 | 2024 | 970 | 0.350 |
Why?
|
Cooking | 1 | 2012 | 309 | 0.350 |
Why?
|
Risk | 8 | 2020 | 9616 | 0.350 |
Why?
|
School Nursing | 2 | 2022 | 33 | 0.350 |
Why?
|
Phenols | 2 | 2024 | 517 | 0.350 |
Why?
|
Eosinophilia | 3 | 2023 | 557 | 0.350 |
Why?
|
Monitoring, Physiologic | 2 | 2024 | 1780 | 0.340 |
Why?
|
Bacteria | 2 | 2023 | 2190 | 0.340 |
Why?
|
Rhinitis | 4 | 2014 | 747 | 0.340 |
Why?
|
Safety | 2 | 2014 | 1151 | 0.330 |
Why?
|
Phenotype | 8 | 2020 | 16575 | 0.330 |
Why?
|
Buffaloes | 1 | 2009 | 14 | 0.330 |
Why?
|
Interleukin-6 | 6 | 2023 | 3210 | 0.330 |
Why?
|
Bacterial Infections | 1 | 2017 | 1390 | 0.330 |
Why?
|
Disease Progression | 15 | 2024 | 13511 | 0.330 |
Why?
|
Occupational Diseases | 1 | 2017 | 1490 | 0.330 |
Why?
|
Genes | 1 | 2013 | 1820 | 0.330 |
Why?
|
Residence Characteristics | 2 | 2022 | 2092 | 0.320 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 3788 | 0.320 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2024 | 326 | 0.320 |
Why?
|
Quinolines | 3 | 2019 | 764 | 0.310 |
Why?
|
Allergy and Immunology | 3 | 2024 | 177 | 0.310 |
Why?
|
Respiratory Hypersensitivity | 3 | 2016 | 271 | 0.310 |
Why?
|
Glucocorticoids | 6 | 2024 | 2159 | 0.300 |
Why?
|
Cohort Studies | 23 | 2024 | 41496 | 0.300 |
Why?
|
Polymorphism, Genetic | 2 | 2017 | 4243 | 0.290 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 983 | 0.290 |
Why?
|
Adult | 54 | 2024 | 221119 | 0.280 |
Why?
|
Boston | 8 | 2018 | 9327 | 0.280 |
Why?
|
Pollen | 3 | 2014 | 81 | 0.280 |
Why?
|
Vitamins | 3 | 2021 | 1634 | 0.270 |
Why?
|
Breath Tests | 5 | 2023 | 299 | 0.260 |
Why?
|
Treatment Outcome | 21 | 2024 | 64681 | 0.260 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6124 | 0.250 |
Why?
|
Length of Stay | 2 | 2018 | 6417 | 0.250 |
Why?
|
Suburban Population | 1 | 2005 | 54 | 0.250 |
Why?
|
Enterovirus Infections | 2 | 2023 | 74 | 0.250 |
Why?
|
Environmental Pollutants | 3 | 2024 | 1276 | 0.250 |
Why?
|
Immunotherapy | 3 | 2020 | 4642 | 0.250 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1232 | 0.240 |
Why?
|
Risk Factors | 22 | 2024 | 74239 | 0.240 |
Why?
|
Disease Susceptibility | 5 | 2021 | 1791 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2024 | 10218 | 0.240 |
Why?
|
Animals, Domestic | 3 | 2010 | 56 | 0.240 |
Why?
|
Pilot Projects | 7 | 2019 | 8642 | 0.240 |
Why?
|
Peak Expiratory Flow Rate | 3 | 2018 | 143 | 0.240 |
Why?
|
Eosinophil Peroxidase | 1 | 2024 | 21 | 0.240 |
Why?
|
Vitamin D Deficiency | 3 | 2020 | 1388 | 0.240 |
Why?
|
Food | 3 | 2018 | 768 | 0.230 |
Why?
|
Th2 Cells | 3 | 2024 | 1071 | 0.230 |
Why?
|
Conjunctivitis, Allergic | 1 | 2005 | 125 | 0.230 |
Why?
|
Lung | 13 | 2024 | 9979 | 0.230 |
Why?
|
Mites | 2 | 2017 | 46 | 0.230 |
Why?
|
Osteolysis | 1 | 2006 | 274 | 0.220 |
Why?
|
Oscillometry | 1 | 2024 | 150 | 0.220 |
Why?
|
Parabens | 1 | 2024 | 114 | 0.220 |
Why?
|
Poverty | 7 | 2024 | 2691 | 0.220 |
Why?
|
Solar Activity | 1 | 2023 | 44 | 0.220 |
Why?
|
Mass Screening | 2 | 2019 | 5426 | 0.220 |
Why?
|
Azetidines | 1 | 2024 | 142 | 0.210 |
Why?
|
Australia | 2 | 2024 | 1246 | 0.210 |
Why?
|
Epithelial Cells | 1 | 2015 | 3671 | 0.210 |
Why?
|
Research Design | 9 | 2024 | 6180 | 0.210 |
Why?
|
Attitude to Health | 1 | 2012 | 2026 | 0.210 |
Why?
|
Age Factors | 8 | 2024 | 18384 | 0.210 |
Why?
|
Interleukin-4 | 2 | 2024 | 1154 | 0.210 |
Why?
|
Practice Guidelines as Topic | 6 | 2018 | 7400 | 0.210 |
Why?
|
Family Characteristics | 2 | 2024 | 992 | 0.210 |
Why?
|
Cholecalciferol | 2 | 2020 | 552 | 0.200 |
Why?
|
Churg-Strauss Syndrome | 1 | 2003 | 75 | 0.200 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1668 | 0.200 |
Why?
|
Arthroplasty, Replacement | 1 | 2006 | 309 | 0.200 |
Why?
|
Endogenous Retroviruses | 1 | 2023 | 111 | 0.200 |
Why?
|
DNA Methylation | 3 | 2023 | 4384 | 0.200 |
Why?
|
Ovalbumin | 1 | 2024 | 671 | 0.200 |
Why?
|
Spain | 1 | 2023 | 489 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1812 | 0.190 |
Why?
|
Stress, Psychological | 1 | 2017 | 4487 | 0.190 |
Why?
|
Pandemics | 7 | 2022 | 8663 | 0.190 |
Why?
|
Inflammation | 10 | 2024 | 10759 | 0.190 |
Why?
|
Environmental Illness | 1 | 2001 | 34 | 0.190 |
Why?
|
Pulmonary Eosinophilia | 1 | 2022 | 78 | 0.190 |
Why?
|
Basophils | 1 | 2024 | 407 | 0.190 |
Why?
|
Muscarinic Antagonists | 1 | 2022 | 134 | 0.190 |
Why?
|
Environment | 2 | 2018 | 1122 | 0.190 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26071 | 0.190 |
Why?
|
Pruritus | 2 | 2023 | 378 | 0.180 |
Why?
|
Antiviral Agents | 3 | 2017 | 3048 | 0.180 |
Why?
|
Cysteine Endopeptidases | 2 | 2021 | 551 | 0.180 |
Why?
|
Dyspnea | 4 | 2024 | 1347 | 0.180 |
Why?
|
Cross-Over Studies | 5 | 2019 | 2082 | 0.180 |
Why?
|
Bone Transplantation | 1 | 2006 | 923 | 0.180 |
Why?
|
Epitope Mapping | 1 | 2021 | 298 | 0.180 |
Why?
|
Young Adult | 19 | 2024 | 59221 | 0.180 |
Why?
|
Comorbidity | 6 | 2024 | 10516 | 0.180 |
Why?
|
Genomics | 2 | 2018 | 5828 | 0.180 |
Why?
|
Epitopes | 2 | 2021 | 2504 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4014 | 0.170 |
Why?
|
Baltimore | 2 | 2019 | 231 | 0.170 |
Why?
|
Respiratory Tract Infections | 2 | 2020 | 1009 | 0.170 |
Why?
|
Nonlinear Dynamics | 1 | 2022 | 492 | 0.170 |
Why?
|
Mucus | 1 | 2022 | 342 | 0.170 |
Why?
|
Filtration | 2 | 2011 | 228 | 0.170 |
Why?
|
Tosyl Compounds | 1 | 2000 | 115 | 0.170 |
Why?
|
Triamcinolone | 1 | 2019 | 68 | 0.170 |
Why?
|
Health Services | 2 | 2017 | 750 | 0.170 |
Why?
|
Leukocyte Count | 5 | 2024 | 1597 | 0.160 |
Why?
|
Seasons | 3 | 2019 | 1518 | 0.160 |
Why?
|
Nasal Provocation Tests | 1 | 1998 | 9 | 0.160 |
Why?
|
Particle Size | 3 | 2019 | 1649 | 0.160 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2019 | 323 | 0.160 |
Why?
|
Sleep Apnea Syndromes | 2 | 2024 | 977 | 0.160 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2020 | 197 | 0.160 |
Why?
|
Infant, Newborn | 7 | 2024 | 26199 | 0.160 |
Why?
|
Extravascular Lung Water | 1 | 2018 | 20 | 0.150 |
Why?
|
Retinal Detachment | 1 | 2023 | 429 | 0.150 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2018 | 11 | 0.150 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 34 | 0.150 |
Why?
|
Airway Obstruction | 1 | 2023 | 660 | 0.150 |
Why?
|
Azithromycin | 2 | 2019 | 199 | 0.150 |
Why?
|
Larynx | 1 | 2023 | 492 | 0.150 |
Why?
|
Body Mass Index | 6 | 2022 | 12952 | 0.150 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5425 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1567 | 0.150 |
Why?
|
Antigens, Fungal | 1 | 2017 | 69 | 0.150 |
Why?
|
Maryland | 1 | 2018 | 277 | 0.150 |
Why?
|
National Institute of Environmental Health Sciences (U.S.) | 1 | 2017 | 7 | 0.150 |
Why?
|
Alloys | 1 | 1998 | 110 | 0.150 |
Why?
|
Regional Medical Programs | 1 | 2018 | 66 | 0.140 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5493 | 0.140 |
Why?
|
Venoms | 1 | 2017 | 94 | 0.140 |
Why?
|
Inhalation Spacers | 1 | 2017 | 4 | 0.140 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 63 | 0.140 |
Why?
|
Symbiosis | 1 | 2019 | 294 | 0.140 |
Why?
|
Glycoproteins | 2 | 2002 | 2203 | 0.140 |
Why?
|
Bedding and Linens | 1 | 2017 | 41 | 0.140 |
Why?
|
Syncope | 1 | 2000 | 428 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2022 | 3092 | 0.140 |
Why?
|
Antibodies, Neutralizing | 3 | 2023 | 1935 | 0.140 |
Why?
|
Polytetrafluoroethylene | 1 | 1998 | 245 | 0.140 |
Why?
|
Population | 1 | 2017 | 141 | 0.140 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.140 |
Why?
|
Th1-Th2 Balance | 1 | 2016 | 38 | 0.140 |
Why?
|
Organizations, Nonprofit | 1 | 2017 | 105 | 0.140 |
Why?
|
Sulfides | 3 | 2019 | 168 | 0.140 |
Why?
|
Bullying | 1 | 2019 | 232 | 0.130 |
Why?
|
Forecasting | 1 | 2005 | 2928 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2765 | 0.130 |
Why?
|
Antigens, Plant | 2 | 2021 | 105 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2020 | 1847 | 0.130 |
Why?
|
Cyclopropanes | 3 | 2019 | 432 | 0.130 |
Why?
|
Patient Preference | 1 | 2023 | 927 | 0.130 |
Why?
|
Longitudinal Studies | 7 | 2022 | 14610 | 0.130 |
Why?
|
Vitamin D | 4 | 2022 | 3301 | 0.130 |
Why?
|
Hospitalization | 7 | 2022 | 10707 | 0.120 |
Why?
|
Middle Aged | 28 | 2024 | 220853 | 0.120 |
Why?
|
Glutathione | 1 | 2018 | 581 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2023 | 80674 | 0.120 |
Why?
|
Child Day Care Centers | 1 | 2016 | 122 | 0.120 |
Why?
|
Drug Resistance | 2 | 2019 | 1594 | 0.120 |
Why?
|
Sinusitis | 2 | 2013 | 990 | 0.120 |
Why?
|
Sex Factors | 4 | 2018 | 10553 | 0.120 |
Why?
|
Insect Proteins | 1 | 2015 | 254 | 0.110 |
Why?
|
Arginine | 1 | 2018 | 920 | 0.110 |
Why?
|
Materials Testing | 1 | 1998 | 865 | 0.110 |
Why?
|
Standard of Care | 1 | 2018 | 550 | 0.110 |
Why?
|
Clinical Protocols | 3 | 2021 | 1436 | 0.110 |
Why?
|
Fluid Therapy | 1 | 2018 | 578 | 0.110 |
Why?
|
Insect Control | 1 | 2014 | 29 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 702 | 0.110 |
Why?
|
Critical Pathways | 1 | 2017 | 475 | 0.110 |
Why?
|
Nebulizers and Vaporizers | 1 | 2014 | 139 | 0.110 |
Why?
|
Massachusetts | 3 | 2017 | 8837 | 0.110 |
Why?
|
PubMed | 1 | 2014 | 129 | 0.110 |
Why?
|
Dietary Supplements | 3 | 2021 | 3410 | 0.110 |
Why?
|
Antigens, Viral | 1 | 2017 | 989 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2017 | 1577 | 0.110 |
Why?
|
Poverty Areas | 1 | 2015 | 263 | 0.110 |
Why?
|
Drug Therapy, Combination | 4 | 2022 | 6304 | 0.110 |
Why?
|
Colony Count, Microbial | 1 | 2013 | 328 | 0.110 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4537 | 0.110 |
Why?
|
Primary Prevention | 2 | 2018 | 1185 | 0.100 |
Why?
|
Administration, Topical | 1 | 2015 | 703 | 0.100 |
Why?
|
Fever | 2 | 2016 | 1618 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1140 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 776 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2017 | 706 | 0.100 |
Why?
|
Skin Care | 1 | 2012 | 56 | 0.100 |
Why?
|
Perinatal Care | 1 | 2014 | 244 | 0.100 |
Why?
|
Self Report | 2 | 2022 | 3727 | 0.100 |
Why?
|
Soot | 2 | 2024 | 221 | 0.100 |
Why?
|
Cattle | 3 | 2024 | 3818 | 0.100 |
Why?
|
Faculty | 1 | 2015 | 383 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1521 | 0.090 |
Why?
|
Cocos | 1 | 2010 | 9 | 0.090 |
Why?
|
Emergency Service, Hospital | 6 | 2023 | 7865 | 0.090 |
Why?
|
Tacrolimus | 1 | 2015 | 736 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1401 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4569 | 0.090 |
Why?
|
Drug Industry | 1 | 2017 | 788 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2013 | 991 | 0.090 |
Why?
|
Dermatophagoides farinae | 1 | 2010 | 19 | 0.090 |
Why?
|
Dietary Proteins | 3 | 2021 | 951 | 0.090 |
Why?
|
New England | 1 | 2013 | 1052 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3200 | 0.090 |
Why?
|
Metabolomics | 1 | 2019 | 1658 | 0.090 |
Why?
|
Anemia, Sickle Cell | 1 | 2018 | 1063 | 0.090 |
Why?
|
Th17 Cells | 1 | 2016 | 794 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1613 | 0.080 |
Why?
|
Mitosporic Fungi | 1 | 2009 | 17 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1472 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10756 | 0.080 |
Why?
|
CpG Islands | 1 | 2014 | 1190 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3201 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4246 | 0.080 |
Why?
|
Ecosystem | 1 | 2013 | 489 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15308 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.080 |
Why?
|
Telemedicine | 2 | 2023 | 3051 | 0.080 |
Why?
|
Income | 1 | 2017 | 1869 | 0.080 |
Why?
|
Rats | 2 | 2017 | 23704 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39126 | 0.070 |
Why?
|
RNA Viruses | 1 | 2009 | 110 | 0.070 |
Why?
|
Pregnancy | 3 | 2022 | 29893 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3251 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 821 | 0.070 |
Why?
|
Premature Birth | 1 | 2020 | 1784 | 0.070 |
Why?
|
Humidity | 2 | 2021 | 205 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2019 | 2770 | 0.070 |
Why?
|
Interleukin-13 | 2 | 2023 | 392 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20119 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1381 | 0.070 |
Why?
|
Administration, Oral | 3 | 2024 | 4015 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2802 | 0.070 |
Why?
|
Prosthesis Failure | 2 | 2006 | 1204 | 0.070 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2006 | 12 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.070 |
Why?
|
Environmental Pollution | 1 | 2008 | 124 | 0.070 |
Why?
|
Overweight | 1 | 2017 | 2418 | 0.070 |
Why?
|
ROC Curve | 2 | 2012 | 3584 | 0.070 |
Why?
|
Respiration Disorders | 1 | 2009 | 366 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18220 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5773 | 0.070 |
Why?
|
Rhinitis, Allergic, Perennial | 2 | 2013 | 59 | 0.070 |
Why?
|
Cytokines | 2 | 2023 | 7386 | 0.060 |
Why?
|
Biomedical Research | 2 | 2018 | 3434 | 0.060 |
Why?
|
Hot Temperature | 1 | 2012 | 1434 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2020 | 6223 | 0.060 |
Why?
|
Exercise Test | 1 | 2013 | 2165 | 0.060 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2006 | 241 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2113 | 0.060 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1723 | 0.060 |
Why?
|
Polysorbates | 1 | 2005 | 44 | 0.060 |
Why?
|
Fatty Acids, Essential | 1 | 2005 | 97 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12052 | 0.060 |
Why?
|
Carbon Monoxide | 2 | 2019 | 547 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2507 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2545 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3354 | 0.060 |
Why?
|
Hygiene | 1 | 2005 | 94 | 0.060 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 7407 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5333 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29687 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3571 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5295 | 0.060 |
Why?
|
Adrenal Insufficiency | 1 | 2006 | 194 | 0.060 |
Why?
|
Computer Simulation | 1 | 1998 | 6224 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6199 | 0.060 |
Why?
|
Joint Prosthesis | 1 | 2006 | 253 | 0.060 |
Why?
|
Cost of Illness | 2 | 2024 | 1936 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2871 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10088 | 0.060 |
Why?
|
Critical Care | 1 | 2016 | 2696 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8247 | 0.050 |
Why?
|
Specific Gravity | 1 | 2022 | 18 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2021 | 22174 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7966 | 0.050 |
Why?
|
Pituitary-Adrenal System | 2 | 2021 | 547 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 189 | 0.050 |
Why?
|
Sulfonamides | 2 | 2024 | 1977 | 0.050 |
Why?
|
Receptors, Interleukin-4 | 1 | 2022 | 64 | 0.050 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2005 | 314 | 0.050 |
Why?
|
Puerto Rico | 1 | 2023 | 378 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Qualitative Research | 2 | 2024 | 3024 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Metered Dose Inhalers | 1 | 2022 | 27 | 0.050 |
Why?
|
Seed Storage Proteins | 1 | 2021 | 15 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4584 | 0.050 |
Why?
|
Buprenorphine | 1 | 2010 | 656 | 0.050 |
Why?
|
Fish Oils | 1 | 2005 | 483 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2021 | 695 | 0.050 |
Why?
|
2S Albumins, Plant | 1 | 2021 | 37 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 287 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2003 | 476 | 0.050 |
Why?
|
Syndrome | 2 | 2020 | 3271 | 0.050 |
Why?
|
Biological Therapy | 1 | 2023 | 139 | 0.050 |
Why?
|
Histamine | 1 | 2023 | 499 | 0.050 |
Why?
|
Africa | 1 | 2023 | 714 | 0.050 |
Why?
|
Treatment Failure | 2 | 2020 | 2643 | 0.050 |
Why?
|
Drug Hypersensitivity | 1 | 2010 | 918 | 0.050 |
Why?
|
Health Personnel | 3 | 2023 | 3337 | 0.050 |
Why?
|
Purines | 1 | 2024 | 609 | 0.050 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 398 | 0.050 |
Why?
|
Oxadiazoles | 1 | 2000 | 94 | 0.050 |
Why?
|
Evidence-Based Medicine | 3 | 2022 | 3691 | 0.040 |
Why?
|
Budesonide | 1 | 2021 | 158 | 0.040 |
Why?
|
Diet | 1 | 2018 | 8048 | 0.040 |
Why?
|
Phenylcarbamates | 1 | 2000 | 38 | 0.040 |
Why?
|
Carnobacteriaceae | 1 | 2019 | 10 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169288 | 0.040 |
Why?
|
Peptide Library | 1 | 2021 | 347 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 848 | 0.040 |
Why?
|
Moraxella | 1 | 2019 | 25 | 0.040 |
Why?
|
Androstadienes | 1 | 2021 | 348 | 0.040 |
Why?
|
Child Welfare | 1 | 2004 | 521 | 0.040 |
Why?
|
Finland | 1 | 2021 | 607 | 0.040 |
Why?
|
Radioallergosorbent Test | 1 | 1999 | 19 | 0.040 |
Why?
|
Skin | 2 | 2024 | 4473 | 0.040 |
Why?
|
Intradermal Tests | 1 | 1999 | 43 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1409 | 0.040 |
Why?
|
Staphylococcus | 1 | 2019 | 153 | 0.040 |
Why?
|
Streptococcus | 1 | 2019 | 197 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 39957 | 0.040 |
Why?
|
Drug Synergism | 1 | 2003 | 1756 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 628 | 0.040 |
Why?
|
Theophylline | 1 | 2019 | 131 | 0.040 |
Why?
|
Biomass | 1 | 2019 | 127 | 0.040 |
Why?
|
Sulfur | 1 | 2019 | 160 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4851 | 0.040 |
Why?
|
Decontamination | 1 | 2019 | 73 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1391 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2006 | 2114 | 0.040 |
Why?
|
Geography | 1 | 2021 | 652 | 0.040 |
Why?
|
Respiratory System | 1 | 2002 | 562 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9055 | 0.040 |
Why?
|
Consensus | 2 | 2023 | 3134 | 0.040 |
Why?
|
Carbon | 1 | 2022 | 665 | 0.040 |
Why?
|
Lubrication | 1 | 1998 | 22 | 0.040 |
Why?
|
Ventilation | 1 | 2019 | 128 | 0.040 |
Why?
|
Aluminum Oxide | 1 | 1998 | 41 | 0.040 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2000 | 229 | 0.040 |
Why?
|
Ornithine | 1 | 2018 | 79 | 0.040 |
Why?
|
Age of Onset | 1 | 2005 | 3307 | 0.040 |
Why?
|
Prednisolone | 1 | 2019 | 324 | 0.040 |
Why?
|
Convalescence | 1 | 2018 | 106 | 0.040 |
Why?
|
Chronic Disease | 3 | 2022 | 9319 | 0.040 |
Why?
|
Cobalt | 1 | 1998 | 148 | 0.040 |
Why?
|
Steroids | 1 | 2003 | 929 | 0.040 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2017 | 29 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 858 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2008 | 2220 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 788 | 0.040 |
Why?
|
Polysomnography | 1 | 2024 | 1848 | 0.040 |
Why?
|
Chromium | 1 | 1998 | 132 | 0.040 |
Why?
|
Acoustics | 1 | 1998 | 243 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1897 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 12985 | 0.030 |
Why?
|
Trachea | 1 | 2023 | 1090 | 0.030 |
Why?
|
Fund Raising | 1 | 2017 | 49 | 0.030 |
Why?
|
Mast Cells | 1 | 2024 | 1392 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7226 | 0.030 |
Why?
|
Nasal Cavity | 1 | 1998 | 304 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2016 | 101 | 0.030 |
Why?
|
Life Change Events | 1 | 2022 | 952 | 0.030 |
Why?
|
Vomiting | 1 | 2000 | 650 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2022 | 58952 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 913 | 0.030 |
Why?
|
Nurse's Role | 1 | 2017 | 188 | 0.030 |
Why?
|
Manometry | 1 | 1998 | 453 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2020 | 442 | 0.030 |
Why?
|
Absenteeism | 1 | 2017 | 247 | 0.030 |
Why?
|
Growth | 1 | 2018 | 365 | 0.030 |
Why?
|
Nigeria | 1 | 2019 | 771 | 0.030 |
Why?
|
Incidence | 2 | 2016 | 21365 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 931 | 0.030 |
Why?
|
Violence | 1 | 2022 | 935 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2022 | 934 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1867 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1624 | 0.030 |
Why?
|
Gestational Age | 1 | 2004 | 3580 | 0.030 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 152 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1838 | 0.030 |
Why?
|
Reoperation | 1 | 2006 | 4303 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 224 | 0.030 |
Why?
|
Surface Properties | 1 | 1998 | 1162 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1550 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 370 | 0.030 |
Why?
|
Puberty | 1 | 2018 | 501 | 0.030 |
Why?
|
Cough | 1 | 2018 | 594 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1147 | 0.030 |
Why?
|
Environmental Health | 1 | 2017 | 289 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2219 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 668 | 0.030 |
Why?
|
Breast Feeding | 1 | 2023 | 1356 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2017 | 432 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 874 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 5993 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2024 | 1814 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2010 | 0.030 |
Why?
|
Population Surveillance | 1 | 2024 | 2598 | 0.030 |
Why?
|
Risk Assessment | 2 | 2018 | 24021 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2010 | 3805 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1598 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12976 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8457 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Patient Care Management | 1 | 2016 | 303 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1644 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8003 | 0.030 |
Why?
|
Social Support | 1 | 2023 | 2175 | 0.030 |
Why?
|
Logistic Models | 2 | 2004 | 13249 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1998 | 1674 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2024 | 2726 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1988 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 989 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1803 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2706 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3027 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 872 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3423 | 0.020 |
Why?
|
Indoles | 1 | 2000 | 1830 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2277 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3821 | 0.020 |
Why?
|
Water | 1 | 1998 | 1410 | 0.020 |
Why?
|
Research | 1 | 2020 | 1976 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9520 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3590 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3418 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17897 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2010 | 59 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 913 | 0.020 |
Why?
|
Health Education | 1 | 2016 | 1049 | 0.020 |
Why?
|
Air Conditioning | 1 | 2009 | 54 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1589 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2724 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3441 | 0.020 |
Why?
|
Expert Testimony | 1 | 2012 | 365 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2489 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4567 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3634 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3155 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2015 | 1048 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4744 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5869 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7571 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9652 | 0.020 |
Why?
|
Cosyntropin | 1 | 2006 | 34 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2493 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5874 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5871 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6486 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22127 | 0.020 |
Why?
|
Proteomics | 1 | 2018 | 3840 | 0.020 |
Why?
|
Primary Health Care | 1 | 2021 | 4678 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2813 | 0.010 |
Why?
|
Neutrophils | 1 | 2017 | 3763 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5842 | 0.010 |
Why?
|
Pain | 1 | 2016 | 5072 | 0.010 |
Why?
|
Parenteral Nutrition | 1 | 2005 | 659 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8536 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9416 | 0.010 |
Why?
|
Oxazoles | 1 | 2000 | 199 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11509 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2006 | 1818 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20588 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1116 | 0.010 |
Why?
|
Body Height | 1 | 2004 | 1566 | 0.010 |
Why?
|
Energy Intake | 1 | 2005 | 2133 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2692 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2688 | 0.010 |
Why?
|
Birth Weight | 1 | 2004 | 2104 | 0.010 |
Why?
|
Infant, Premature | 1 | 2004 | 2106 | 0.010 |
Why?
|
Feces | 1 | 2000 | 1490 | 0.010 |
Why?
|
RNA, Viral | 1 | 2000 | 2839 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6067 | 0.010 |
Why?
|